NCT04798898 Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation
| NCT ID | NCT04798898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Liver Metastasis Colon Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-11-14 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-11-14 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To examine radio frequency ablation as a treatment supplement to stimulate immunogenicity and improve survival for patients undergoing curative-intent surgery for colorectal liver metastases.
Eligibility Criteria
Inclusion Criteria: * Patients with colorectal liver metastases planned for resection * At least one tumor size \>=3cm * Performance status 0-1 Exclusion Criteria: * Liver cirrhosis * Extrahepatic metastases that can not be addressed curatively * Other malignant diseases within 5 years prior to diagnosis * Prior RFA treatment
Contact & Investigator
Frank V Mortensen, MD, DMSc
PRINCIPAL INVESTIGATOR
Aarhus University Hospital
Frequently Asked Questions
Who can join the NCT04798898 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Liver Metastasis Colon Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04798898 currently recruiting?
Yes, NCT04798898 is actively recruiting participants. Contact the research team at jakob.kirkegaard@auh.rm.dk for enrollment information.
Where is the NCT04798898 trial being conducted?
This trial is being conducted at Aarhus, Denmark.
Who is sponsoring the NCT04798898 clinical trial?
NCT04798898 is sponsored by University of Aarhus. The principal investigator is Frank V Mortensen, MD, DMSc at Aarhus University Hospital. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.